SCHEMBL3783768

SCHEMBL3783768

CCCOc1ccc(Cl)c(OCCC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.49
KDM4E B2RXH2 3/20 0.47
L3MBTL1 Q9Y468 4/20 0.46
MAPT P10636 4/20 0.45
KMT2A Q03164 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MEN1 O00255 2/20 0.45
USP2 O75604 2/20 0.45
POLB P06746 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
ALOX12 P18054 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MDM2 Q00987 1/20 0.43
FABP4 P15090 1/20 0.43
LTA4H P09960 1/20 0.43
GPR84 Q9NQS5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790208 0.92 KDM4E (0.51) KDM4EL3MBTL1MAPTKMT2AALDH1A1
SCHEMBL11841046 0.91 CSNK2A1 (0.45) CSNK2A1KDM4EL3MBTL1MAPTKMT2A
SCHEMBL13064498 0.89 GPR84 (0.53) CSNK2A1KDM4EL3MBTL1MAPTKMT2A
SCHEMBL15494435 0.87 NR5A1 (0.51) KDM4EL3MBTL1MAPTTDP1LTA4H
SCHEMBL3787950 0.85 CSNK2A1 (0.62) CSNK2A1KDM4EL3MBTL1MAPTKMT2A
SCHEMBL13261015 0.84 KDM4E (0.64) KDM4EL3MBTL1KMT2AALDH1A1MEN1
SCHEMBL26667637 0.82 ALDH1A1 (0.54) CSNK2A1KDM4EL3MBTL1MAPTKMT2A
SCHEMBL8560597 0.82 MAPT (0.49) CSNK2A1KDM4EL3MBTL1MAPTKMT2A
SCHEMBL18998218 0.81 KDM4E (0.45) KDM4EL3MBTL1MAPTKMT2AALDH1A1
SCHEMBL12905265 0.81 MCL1 (0.57) KDM4EKMT2AALDH1A1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CSNK2A1 4767/4885KDM4E 2606/4885L3MBTL1 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.